Teladoc Health, Inc.
$1.40B- Market cap
- $1.14B
- Debt
- +$1.04B
- Cash
- −$781.08M
Capital structure 52% equity / 48% debt · EV / Revenue 0.55x · EV / EBITDA 4.74x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: TDOC stock price near parity vs GBX $6.28 current versus $5.75 implied using P/S multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at GBX's multiple
Implied fair value · at TDOC's multiple
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Multiple discount
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: TDOC FY 2025 (ended Dec 31, 2025) · GBX FY 2025 (ended Aug 31, 2025). Fiscal years are not aligned.
Trendline
Ten fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 52% equity / 48% debt · EV / Revenue 0.55x · EV / EBITDA 4.74x
Capital structure 43% equity / 57% debt · EV / Revenue 0.86x · EV / EBITDA 6.02x
GBX carries the larger enterprise value at $2.78B against $1.40B; TDOC trades on the lower EV / Revenue multiple (0.55x vs 0.86x); TDOC on the lower EV / EBITDA (4.74x vs 6.02x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
TELADOC HEALTH, INC. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
THE GREENBRIER COMPANIES, INC. · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.75x
1.14x
Net debt / EBITDA
Leverage against operating earnings
0.87x
3.13x
Cash and equivalents
Liquid reserves on the balance sheet
$781.08M
$306.10M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
$1.04B
$1.75B
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.